vs
STANDARD BIOTOOLS INC.（LAB）与Volato Group, Inc.（SOAR）财务数据对比。点击上方公司名可切换其他公司
Volato Group, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$24.9M vs $19.6M），Volato Group, Inc.净利率更高（14.5% vs -177.4%，领先191.9%），Volato Group, Inc.同比增速更快（13632.0% vs -11.5%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Volato集团旗下的Volato飞机复合材料公司是巴西一家专业飞机制造企业，专注于航空制造领域的业务，在巴西航空制造业中开展相关经营活动。
LAB vs SOAR — 直观对比
营收规模更大
SOAR
是对方的1.3倍
$19.6M
营收增速更快
SOAR
高出13643.5%
-11.5%
净利率更高
SOAR
高出191.9%
-177.4%
损益表 — Q3 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $24.9M |
| 净利润 | $-34.7M | $3.6M |
| 毛利率 | 48.5% | 15.2% |
| 营业利润率 | -168.5% | 3.5% |
| 净利率 | -177.4% | 14.5% |
| 营收同比 | -11.5% | 13632.0% |
| 净利润同比 | -28.8% | 121.3% |
| 每股收益（稀释后） | $-0.09 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABSOAR
| Q3 25 | $19.6M | — | ||
| Q2 25 | $21.8M | $24.9M | ||
| Q1 25 | $40.8M | $25.5M | ||
| Q3 24 | $22.1M | $38.5M | ||
| Q2 24 | $22.5M | — | ||
| Q1 24 | $45.5M | — | ||
| Q4 23 | $28.2M | $3.2M | ||
| Q3 23 | $25.4M | $3.7M |
净利润LABSOAR
| Q3 25 | $-34.7M | — | ||
| Q2 25 | $-33.5M | $3.6M | ||
| Q1 25 | $-26.0M | $455.0K | ||
| Q3 24 | $-26.9M | $-4.4M | ||
| Q2 24 | $-45.7M | — | ||
| Q1 24 | $-32.2M | — | ||
| Q4 23 | $-19.8M | — | ||
| Q3 23 | $-21.0M | $-11.8M |
毛利率LABSOAR
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | 15.2% | ||
| Q1 25 | 48.4% | 17.6% | ||
| Q3 24 | 54.9% | 16.6% | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — | ||
| Q4 23 | 47.6% | — | ||
| Q3 23 | 44.0% | 8.7% |
营业利润率LABSOAR
| Q3 25 | -168.5% | — | ||
| Q2 25 | -118.1% | 3.5% | ||
| Q1 25 | -80.8% | 9.9% | ||
| Q3 24 | -120.9% | 5.5% | ||
| Q2 24 | -134.5% | — | ||
| Q1 24 | -132.2% | — | ||
| Q4 23 | -75.9% | — | ||
| Q3 23 | -83.5% | -50.2% |
净利率LABSOAR
| Q3 25 | -177.4% | — | ||
| Q2 25 | -153.7% | 14.5% | ||
| Q1 25 | -63.8% | 1.8% | ||
| Q3 24 | -122.0% | -11.5% | ||
| Q2 24 | -203.3% | — | ||
| Q1 24 | -70.6% | — | ||
| Q4 23 | -70.2% | — | ||
| Q3 23 | -82.8% | -323.6% |
每股收益（稀释后）LABSOAR
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | $0.75 | ||
| Q1 25 | $-0.07 | $0.03 | ||
| Q3 24 | $-0.07 | $-3.76 | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — | ||
| Q4 23 | $-0.24 | — | ||
| Q3 23 | $-0.27 | $-0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $-7.1M |
| 总资产 | $539.6M | $13.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABSOAR
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — | ||
| Q4 23 | $51.7M | — | ||
| Q3 23 | $79.7M | — |
总债务LABSOAR
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — | ||
| Q4 23 | $63.5M | — | ||
| Q3 23 | $64.6M | — |
股东权益LABSOAR
| Q3 25 | $399.7M | — | ||
| Q2 25 | $424.5M | $-7.1M | ||
| Q1 25 | $454.6M | $-15.8M | ||
| Q3 24 | $489.3M | $-19.6M | ||
| Q2 24 | $510.3M | — | ||
| Q1 24 | $577.3M | — | ||
| Q4 23 | $-148.1M | $14.8M | ||
| Q3 23 | $-131.7M | $-34.8M |
总资产LABSOAR
| Q3 25 | $539.6M | — | ||
| Q2 25 | $557.0M | $13.0M | ||
| Q1 25 | $579.6M | $23.4M | ||
| Q3 24 | $681.5M | $47.9M | ||
| Q2 24 | $708.7M | — | ||
| Q1 24 | $777.7M | — | ||
| Q4 23 | $323.1M | $71.7M | ||
| Q3 23 | $339.3M | $70.4M |
负债/权益比LABSOAR
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $848.0K |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.24× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABSOAR
| Q3 25 | $-22.2M | — | ||
| Q2 25 | $-20.7M | $848.0K | ||
| Q1 25 | $-30.3M | $-312.0K | ||
| Q3 24 | $-27.9M | $-3.1M | ||
| Q2 24 | $-39.0M | — | ||
| Q1 24 | $-62.5M | — | ||
| Q4 23 | $-14.1M | $-30.4M | ||
| Q3 23 | $-11.4M | $-10.9M |
自由现金流LABSOAR
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q3 24 | $-30.1M | $-3.2M | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — | ||
| Q4 23 | $-14.1M | $-31.0M | ||
| Q3 23 | $-12.3M | $-11.1M |
自由现金流率LABSOAR
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q3 24 | -136.4% | -8.2% | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — | ||
| Q4 23 | -50.2% | -958.0% | ||
| Q3 23 | -48.6% | -304.7% |
资本支出强度LABSOAR
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | 0.0% | ||
| Q1 25 | 12.4% | 0.0% | ||
| Q3 24 | 10.2% | 0.1% | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — | ||
| Q4 23 | 0.3% | 19.7% | ||
| Q3 23 | 3.6% | 7.4% |
现金转化率LABSOAR
| Q3 25 | — | — | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | -0.69× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SOAR
暂无分部数据
